Categories

What Client Says

Bolshoi vibor kosmetiki. Dostavka 3 nedeli, no upakovan tovar horosho."

Kate

Большой выбор интересной косметики на любой случай. Заказывала для себя и мамы, остались довольны. Доставка в Киев 2 недели."

Ольга

Посылка в Саратов шла 15 дней. Косметика оригинальная, упакована хорошо"

Елена Козлова

Large selection of vitamins at a good price"

Den

Большой выбор косметики и биодобавок. Заказал несколько средств по выгодной цене. В Крым доставляли чуть больше 2х недель."

Александр

Много косметики мировых брендов, а также редкая биокосметика. Доставили посылку через 12 дней в Украину."

Лилия

A lot of bio-cosmetics. The package arrived 15 days later in Rome."

Annet

Много витаминов и БАДов европейского качества. Вежливый персонал."

Натали

Большой выбор европейских лекарств, доставка до 14 дней. Нашла все, что искала"

Ольга

Оперативно доставили лекарство по рецепту в Екатеринбург"

Валерий

Много не только лекарств, а и косметических средств европейского производства, что очень радует"

Вика

Slim figure

Slim figure

Oli-oly

Подкатегории

Active filters

Zevalin, 1.6 mg / ml
€21,677.50
Zometa ,4MG/100ML
€301.55
JANSSEN,Darzalex (Daratumumab) ,100 mg / 5ml, 1pcs
JANSSEN,Darzalex (Daratumumab) ,400 mg / 20ml, 1pcs
€3,033.36
LITAK, 2MG/ML  5 ML
€672.72
NOVARTIS,Jakavi (Ruxolitinib) ,15 mg, 56 tablets
€5,910.63
NOVARTIS,Jakavi (Ruxolitinib) ,20 mg, 56 tablets
€5,910.63
NOVARTIS,Jakavi (Ruxolitinib) ,5 mg, 56 tablets
€2,998.19
Zaltrap, 4 ml
€715.82
Zaltrap, 8 ml
€1,200.20
SANOFI ,Jevtana (Cabazitaxel) ,60 mg ,1 Bottle
€5,926.62

Semisynthetic antitumor agent of plant origin, obtained by chemical synthesis from natural raw materials - European yew needles (Taxus baccata). White or almost white powder, highly lipophilic and practically insoluble in water. The molecular weight of 861.9.

Semisynthetic antitumor agent of plant origin, obtained by chemical synthesis from natural raw materials - European yew needles (Taxus baccata). White or almost white powder, highly lipophilic and practically insoluble in water. The molecular weight of 861.9.

The package with the drug in the form for parenteral administration should be stored in a dark place and out of the reach of children at a temperature of no higher than 30 ° C. The shelf life of lyophilized powder for solution preparation is 3 years.

on prescription

Manufacturer ASPEN

The drug is a medicine that suppresses the effects of male sex hormone (testosterone) (non-steroidal antiandrogen).

Used to treat locally advanced prostate cancer and a high risk of disease progression.

The drug is a medicine that suppresses the effects of male sex hormone (testosterone) (non-steroidal antiandrogen).

Used to treat locally advanced prostate cancer and a high risk of disease progression.

€21,677.50

treatment of recurrent or refractory CD20-positive indolent B-cell non-Hodgkin lymphoma in adult patients;

consolidation therapy after achieving remission in previously untreated patients with follicular lymphoma.

Kisplyx (Kisplyx) is indicated in combination with everolimus for the treatment of adult patients with renal cell carcinoma (PAC) after one previous vascular endothelial growth factor (VEGF) -targeted therapy.

Kisplyx (Kisplyx) is indicated in combination with everolimus for the treatment of adult patients with renal cell carcinoma (PAC) after one previous vascular endothelial growth factor (VEGF) -targeted therapy.

€301.55

The active substance in the drug is called zoledronic acid and is a representative of a group of substances called bisphosphonates. Zoledronic acid works by binding to bones and slowing down the speed of bone remodeling.

Idelalisib (idelalisib) is used to treat relapsing chronic lymphocytic leukemia, relapsing follicular non-Hodgkin B-cell lymphoma, and small cell lymphocytic lymphoma. Sidelig is used in combination with rituximab (rituximab).

1 ml of concentrate contains: active substance: daratumumab - 20 mg; excipients: glacial acetic acid - 0.186 mg, sodium acetate trihydrate - 2.967 mg, sodium chloride - 3.506 mg, mannitol - 25.500 mg, polysorbate-20 - 0.400 mg, water for injection - up to 1.0 ml

€3,033.36

1 ml of concentrate contains: active substance: daratumumab - 20 mg; excipients: glacial acetic acid - 0.186 mg, sodium acetate trihydrate - 2.967 mg, sodium chloride - 3.506 mg, mannitol - 25.500 mg, polysorbate-20 - 0.400 mg, water for injection - up to 1.0 ml

The multicomponent composition regimens: osteogenic sarcoma, uterine sarcoma, lymphosarcoma, embryonal rhabdomyosarcoma, and pleural mesothelioma of the peritoneum, carcinoid tumors (including bronchogenic carcinoma, small cell lung cancer, thyroid cancer), pheochromocytoma, insulinoma, neuroblastoma, CNS tumor (glioma).

The multicomponent composition regimens: osteogenic sarcoma, uterine sarcoma, lymphosarcoma, embryonal rhabdomyosarcoma, and pleural mesothelioma of the peritoneum, carcinoid tumors (including bronchogenic carcinoma, small cell lung cancer, thyroid cancer), pheochromocytoma, insulinoma, neuroblastoma, CNS tumor (glioma).

€672.72

Litak is intended for the treatment of hairy cell leukemia. Litak solution is indicated as a second-line drug for the treatment of patients with recurrent or non-treatable lymphoproliferative diseases of low malignancy, such as follicular and diffuse non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Valdenström macroglobulinemia.

Kaitruda is the brightest representative of the monoclonal antibody group. Numerous clinical studies, practical experience with Keitruda, reviews of oncologists and patients suggest the uniqueness of this drug. Its feature is the ability to obtain favorable results even in the treatment of metastatic forms of malignant tumors

The introduction of enzyme combinations is a proven method of supporting the immune system for many decades. An additional balanced diet Wobe-Mucos is designed for dietary treatment of cancer patients during and after chemotherapy and radiation therapy.

The introduction of enzyme combinations is a proven method of supporting the immune system for many decades. An additional balanced diet Wobe-Mucos is designed for dietary treatment of cancer patients during and after chemotherapy and radiation therapy.

€5,910.63

treatment of patients with myelofibrosis, including primary myelofibrosis and secondary myelofibrosis, developed as a result of true polycythemia and essential thrombocythemia.

In August 2017, the EU approved Novartis AG's Kisqali (ribocyclib) as the first line of treatment for breast cancer.

€5,910.63

treatment of patients with myelofibrosis, including primary myelofibrosis and secondary myelofibrosis, developed as a result of true polycythemia and essential thrombocythemia.

€2,998.19

treatment of patients with myelofibrosis, including primary myelofibrosis and secondary myelofibrosis, developed as a result of true polycythemia and essential thrombocythemia.

Zikadia has been developed for the treatment of non-small cell lung cancer, which has positive anaplastic lymphoma kinase with the ineffectiveness of other methods. The positive effect was confirmed after a series of trials on living patients.

In August 2017, the EU approved Novartis AG's Kisqali (ribocyclib) as the first line of treatment for breast cancer.

Pregnancy and lactation

Controlled studies of the use of Arisept during pregnancy and lactation have not been conducted. There is no information on the removal of donepezil with breast milk. The drug should be prescribed to pregnant women only if the expected benefit of treatment exceeds the possible risk to the fetus.

on prescription

Manufacturer PFIZER

intoxication with folic acid antagonists (methotrexate, trimethoprim, pyrimethamine);

prevention of the toxic effects of methotrexate when used in high and high doses;

colorectal cancer (as part of complex therapy with fluorouracil)

intoxication with folic acid antagonists (methotrexate, trimethoprim, pyrimethamine);

prevention of the toxic effects of methotrexate when used in high and high doses;

colorectal cancer (as part of complex therapy with fluorouracil)

Lymphoblastic leukemia, soft tissue sarcoma, osteogenic sarcoma, Ewing's sarcoma, breast cancer, thyroid cancer, Wilms tumor, neuroblastoma, bladder cancer, stomach cancer, ovarian cancer, lymphogranulomatosis, non-Hodgkin lymphoma, trophoblastic tumors.

€715.82

Concentrate for solution for infusion, 100 mg / 4 ml and 200 mg / 8 ml

Description

Transparent colorless or pale yellow liquid, free from mechanical impurities.

€1,200.20

Concentrate for solution for infusion, 100 mg / 4 ml and 200 mg / 8 ml

Description

Transparent colorless or pale yellow liquid, free from mechanical impurities.

€5,926.62

Jevtana is the latest generation cytotoxic drug. According to the active substance, Cabazitaxel, the Dzhevtan preparation belongs to antitumor alkaloids - biological medicines of natural origin. Cabazitaxel has a destructive effect on tumor cells. Suppressing the activity of the tubulin protein, which is part of the intracellular protein structures - microtubules, Dzhevtana inhibits the process of division of tumor cells.

Patients with lymphoma and multiple myeloma to enhance the mobilization of hematopoietic stem cells into the peripheral bloodstream to collect them and subsequent autotransplantation in combination with G-CSF

Dietary supplements

Under the order

{gformbuilderpro:1}